ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Hippocampal damage in sepsis induced by lipopolysaccharide: The neuroprotective effects of pregabalin in a rat model

Rahime Aslankoc, Ozlem Ozmen.



Abstract
Download PDF Cited by 1 ArticlesPost

Aim: An excessive immune response to bacterial infections can lead to sepsis, a condition with a high mortality rate. Lipopolysaccharide (LPS)-induced inflammation and oxidative stress cause hippocampal injury. We aimed to investigate the antioxidant, anti-inflammatory and neurogenic effects of pregabalin (PG) against hippocampal injury induced by LPS.
Material and Methods: Twenty-four rats were divided into three different groups (Control, LPS (5 mg/kg), and LPS+PG (30 mg/kg)). Six hours after LPS administration, animals were sacrificed, and the hippocampus tissue was gathered for biochemical, histopathological, and immunohistochemical research.
Results: Biochemical and immunohistochemical analyses revealed the increased levels of total oxidant status (TOS), oxidative stress index (OSI), tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β) and decreased expressions of total antioxidant status (TAS), brain-derived neurotrophic factor (BDNF), and sirtuin-1 (SIRT-1) in LPS group. In addition, histopathological analyses detected degenerative neurons, hyperemia, and edema.
Conclusion: PG treatment reversed biochemical and immunohistochemical parameters and improved hyperemia, edema, and degenerative changes. In conclusion, PG increased BDNF and SIRT-1 levels by inhibiting inflammation and oxidative stress.

Key words: BDNF; hippocampus; pregabalin; sepsis; SIRT-1







Bibliomed Article Statistics

40
18
29
28
21
21
26
40
28
37
18
4
R
E
A
D
S

13

11

12

13

12

10

18

16

12

32

26

2
D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.